Cargando…
Mediator complex subunit 12 is a gatekeeper of SARS-CoV-2 infection in breast cancer cells
Autores principales: | Zhang, Shengjie, Liu, Fabao, Halfmann, Peter, Behrens, Ryan T., Liu, Peng, Mcilwain, Sean J., Ong, Irene M., Donahue, Kristine, Wang, Yidan, Kawaoka, Yoshihiro, Sherer, Nathan, Xu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372481/ https://www.ncbi.nlm.nih.gov/pubmed/34423104 http://dx.doi.org/10.1016/j.gendis.2021.08.001 |
Ejemplares similares
-
Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual
por: Halfmann, Peter J, et al.
Publicado: (2022) -
Persisting benefits 12–18 months after discontinuation of pubertal metformin therapy in low birthweight girls
por: Ong, Ken, et al.
Publicado: (2007) -
The landscape of antibody binding in SARS-CoV-2 infection
por: Heffron, Anna S., et al.
Publicado: (2021) -
Discovery of 3-((3-amino-1H-indazol-4-yl)ethynyl)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide (AKE-72), a potent Pan-BCR-ABL inhibitor including the T315I gatekeeper resistant mutant
por: El-Damasy, Ashraf K., et al.
Publicado: (2023) -
Peer review without gatekeeping
por: Eisen, Michael B, et al.
Publicado: (2022)